GGrantIndex
← Search

Biostatistics Core Facility

$213,098P30FY2025CANIH

University Of Chicago, Chicago IL

Investigators

Linked publications, trials & patents

Paper 39661064Paper 39579248Paper 39438113Paper 39374047Paper 39270007Paper 39141403Paper 39114540Paper 39108474Paper 39071306Paper 39069988Paper 38883758Paper 38881356Paper 38849889Paper 38810242Paper 38771643Paper 38752924Paper 38735044Paper 38716867Paper 38691450Paper 38632339Paper 38561491Paper 38548994Paper 38536082Paper 38533736Paper 38496521Paper 38427437Paper 38421866Paper 38381713Paper 38294692Paper 38294689Paper 38293065Paper 38219706Paper 38213818Paper 38190286Paper 38186960Paper 38175791Paper 38155245Trial NCT02573363Trial NCT02573220Trial NCT02542202Trial NCT02540876Trial NCT02485535Trial NCT02420210Trial NCT02399371Trial NCT02389517Trial NCT02366819Trial NCT02333188Trial NCT02333162Trial NCT02275533Trial NCT02258659Trial NCT02213913Trial NCT02199665Trial NCT02122172Trial NCT02046421Trial NCT02012296Trial NCT01949740Trial NCT01861301Trial NCT01696955Trial NCT01576172Trial NCT01307618Trial NCT01281176Trial NCT01278615Trial NCT01267266Trial NCT01256385Trial NCT01208051Trial NCT01174264Trial NCT01122888Trial NCT01076543Trial NCT01064622Trial NCT00859937Trial NCT00720174Trial NCT00504153Trial NCT00436579Trial NCT00387335Trial NCT00381641Trial NCT00376688Trial NCT00369551Trial NCT00351975Trial NCT00303862Trial NCT00290472Trial NCT00265798Trial NCT00126542Trial NCT00095784Trial NCT00091026Trial NCT00087373Trial NCT00062075Trial NCT00058019Trial NCT00055913Trial NCT00039416Trial NCT00027703Trial NCT00023946Patent 7192711Patent 6870037Patent 6482934Patent 6387619Patent 6043216Patent 5916752Patent 5786344Patent 5698686Patent 5618917

Abstract

The Biostatistics Core Facility (BCF) provides state-of-the-art statistical support for University of Chicago Medicine Comprehensive Cancer Center (UCCCC) investigators engaged in clinical, translational, basic, and population sciences research. BCF helps UCCCC investigators meet their scientific research objectives by ensuring that studies are adequately powered, and that the data are appropriately analyzed and interpreted. Careful consideration of sources of variation, variability, multiplicity, and potential confounding variables is needed to reduce false positive (and false negative) findings. Appropriate study design also reduces the occurrence of equivocal findings. Input into data collection and data management processes can reduce errors, prevent or reduce the amount of missing data, and improve overall data quality. BCF collaborates closely with UCCCC investigators to attain these goals. The services provided include: (i) assistance with study design and data analysis plans; (ii) protocol development, randomization, and statistical analysis for phase I, phase II, and phase III clinical trials; (iii) assistance in the design and analysis of retrospective and prospective observational studies; (iv) analysis of genomic and other high-dimensional data; (v) statistical analysis support for basic science and animal research projects. Advances in statistical methodology related to cancer research is also an important goal. In the current CCSG cycle, BCF has supported 86 unique UCCCC members, 82 clinical trials, 32 peer-reviewed cancer-related grants (78% NCI) and 180 peer reviewed publications (28% in journals with impact factor ≥ 10). In summary, the BCF is dedicated to providing UCCCC investigators with high-level statistical support to facilitate cancer research and to meet the goals of the Strategic Plan.

View original record on NIH RePORTER →